TTY Biopharm Company Limited would receive milestone payment from German pharmaceutical company for co-development of liposome product-Pegylipo in Europe. The Company has co-developed with German pharmaceutical company for liposome product-Pegylipo in European markets. Fourth patient has been recruited for clinical trial and the Company will receive milestone payment of EUR 540,000 based on agreement.